In Vivo Role of Flt3 Ligand and Dendritic Cells in NK Cell Homeostasis
Author(s) -
Martin Guimond,
Aharon G. Freud,
Hsiaoyin Mao,
Jianhua Yu,
Bradley W. Blaser,
Jeffrey Leong,
Jeffrey VanDeusen,
Adrienne M. Dorrance,
Jianying Zhang,
Crystal L. Mackall,
Michael A. Caligiuri
Publication year - 2010
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.0900685
Subject(s) - cd11c , microbiology and biotechnology , homeostasis , dendritic cell , population , biology , in vivo , interleukin 12 , chemistry , interleukin 15 , immunology , immune system , interleukin , in vitro , cytokine , cytotoxic t cell , phenotype , biochemistry , medicine , environmental health , gene
IL-15 is required for NK cell development and homeostasis in vivo. Because IL-15 is presented in trans via its high-affinity IL-15Ralpha-chain to cells expressing the IL-15Rbetagamma complex, we postulated that certain IL-15-bearing cells must be required for NK cell homeostasis. Using IL-15(WT/WT) and IL-15(-/-) mice, bone marrow chimeras with normal cellularity, and a selective depletion of CD11c(hi) dendritic cells (DCs), we demonstrate that ablation of the resting CD11c(hi) DC population results in a highly significant decrease in the absolute number of mature NK cells. In contrast, administration of Flt3 ligand increases the CD11c(hi) DC population, which, when expressing IL-15, significantly expands mature NK cells via enhanced survival and proliferation. In summary, a CD11c(hi) DC population expressing IL-15 is required to maintain NK cell homeostasis under conditions of normal cellularity and also is required to mediate Flt3 ligand-induced NK cell expansion in vivo.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom